0:00
24:10
The FDA's rejection of MDMA as a treatment may well be a short-term setback for legally helping people with PTSD and other disorders. Mason Marks of Harvard Law School’s Petrie-Flom Center for Health Law Policy offers his assessment.
Hosted on Acast. See acast.com/privacy for more information.
Mais episódios de "Cato Daily Podcast"
Não percas um episódio de “Cato Daily Podcast” e subscrevê-lo na aplicação GetPodcast.